Comparison Between the Effects of Soy Milk and Non-Fat Cow Milk on Lipid Profile and Lipid Peroxidation in Patients With Primary Hypercholesterolemia

Nutrition

Volumn 20, Issue 2, 2004, Pages 200-204

  Bricarello, Liliana P ^b   Kasinski, Nelson ^b   Bertolami, Marcelo C ^b   Faludi, Andre ^b   Pinto, Leonor A ^b   Relvas, Waldir G M ^b   Izar, Maria C O ^b   Ihara, Silvia S M ^b   Tufik, Sergio ^b   Fonseca, Francisco A H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Lipid peroxidation; Lipoproteins; Soy milk

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPID; LIPOPROTEIN; THIOBARBITURIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; LIPID PEROXIDATION; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MILK; OUTPATIENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 10744233809     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2003.10.005     Document Type: Article

References (35)

1. Sirtori C.R., Lovatti M.R., Manzoni C., et al. Soy and cholesterol reduction clinical experience . J Nutr. 125:1995;598S.
2. Nagata C., Takatsuka N., Kurisu Y., et al. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr. 128:1998;209.
3. Kapiotis S., Hermann M., Held I., et al. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL-oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscl Thromb Vasc Biol. 17:1997;2868.
4. Exner M., Hermann M., Hofbauer R., et al. Genistein prevents the glucose autoxidation mediated atherogenic modification of low-density lipoprotein. Free Radic Res. 34:2001;101.
5. Anderson J.W., Johnstone B.M., Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 333:1995;276.
6. Krauss R.M., Deckelbaum R.J., Ernst N., et al. Dietary guidelines for healthy Americans adults. Circulation. 94:1996;1795.
7. Erdman J.W. Jr. Soy protein and cardiovascular disease. A statement for healthcare professionals from the nutrition committee of the AHA. Circulation. 102:2000;2555.
8. Food labeling, health claims, soy protein, and coronary heart disease. Fed Reg. 57:1999;699.
9. Soy protein and health discovering a role for soy protein in the fight against coronary heart disease . 1996;Marimac Communications, Houston, TX.
10. Huff M.W., Carroll K.K. Effects of dietary protein on turnover, oxidation, and absorption of cholesterol, and on steroid excretion in rabbits. J Lipid Res. 21:1980;546.
11. Damasceno D.R.T., Goto H., Rodrigues F.M.D., et al. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. J Nutr. 130:2000;2641.
12. Anthony M.S., Clarkson T.B., Williams J.K. Effects of soy isoflavones on atherosclerosis potential mechanisms . Am J Clin Nutr. 68:1998;1390S.
13. Mezei O., Banz W.J., Steger R.W., et al. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murin RAW 264.7 cells. J Nutr. 133:2003;1238.
14. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486.
15. Karvetti R.L., Knuts J.R. Validity of the 24-hour dietary recall. J Am Diet Assoc. 85:1985;1437.
16. Karkeck J.M. Improving the use of dietary survey methodology. J Am Diet Assoc. 87:1987;869.
17. Basiots P.P. Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence. J Nutr. 117:1987;1138.
18. Philippi ST, Szarfac SC, Laterza CR. Virtual Nutri: sistema de análise nutricional [computer program]. Version 1.0. São Paulo, 1996.
19. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499.
20. Okhawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:1979;351.
21. Hixson J., Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 31:1990;545.
22. Carrol K.K., Kurowska E.M. Soy consumption and cholesterol reduction review of animal and human studies . J Nutr. 125:1995;594S.
23. Wong W.W., Smith E.O., Stuff J.E., et al. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 68:1998;1385S.
24. Sidhu G.S., Oakenfull D.G. A mechanism for the hypocholesterolaemic activity of saponins. Br J Nutr. 55:1986;643.
25. Potter S.M., Bakhit R.M., Essex-Sorlie D., et al. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr. 58:1993;501.
26. Potter S.M. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr. 125:1995;606S.
27. Sirtori C.R., Pazzucconi F., Colombo L., et al. Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins. Br J Nutr. 82:1999;91.
28. Khosla P., Samman S., Carroll K.K. Decrease receptor-mediated LDL catabolism in casein-fed rabbits precedes the increase in plasma cholesterol levels. J Nutr Biochem. 2:1991;203.
29. Zhang Z.J., Sniderman A.D., Kalant D., et al. The role of amino acids in apoB100 synthesis and catabolism in human HepG2 cells. J Biol Chem. 268:1993;26920.
30. Chinetti G., Gbaguidi F.G., Griglio S., et al. CLA-1/SR-B1 is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation. 101:2000;2411.
31. Chinetti G., Lestavel S., Bocher V., et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA 1 pathway. Nat Med. 7:2001;53.
32. McDowell A., Young I.S., Wisdon G.B. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease. J Pharm Pharmacol. 54:2002;1651.
33. Tornvall P., Waeg G., Nilsson J., Hamsten A., Regnstrom J. Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis. 167:2003;347.
34. Ordovas J.M. The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc. 58:1999;171.
35. Pedro-Botet J., Schaefer E.J., Bakker-Arkema R.G., et al. Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis. 158:2001;183.